Regenxbio (RGNX) EBT Margin (2014 - 2025)
Regenxbio's (RGNX) quarterly EBT Margin came in at 330.86% in Q4 2025, up 64489.0% year-on-year from N/an in Q4 2024, and up 250.23% quarter-over-quarter from 220.23% in Q3 2025.
Regenxbio (RGNX) EBT Margin (2014 - 2025) Analysis & Trends
Regenxbio's EBT Margin history runs 12 years deep, the most recent figure standing at 330.86% for Q4 2025.
- On a quarterly basis, EBT Margin rose 64489.0% year-over-year to 330.86% in Q4 2025; TTM through Dec 2025 was 26.03%, a 28240.0% increase from a year earlier, with the FY2025 full-year figure at 342.72%, down 7018.0% from the prior year.
- EBT Margin grew to 330.86% in Q4 2025 per RGNX's latest filing, from 220.23% in the prior quarter.
- Across five years, EBT Margin topped out at 703.02% in Q4 2022 and bottomed at 481.95% in Q1 2024.
- The 5-year median for EBT Margin is 254.98% (2021), against an average of 174.58%.
- Across the five-year window, EBT Margin slumped 98650 bps in 2023 and soared 64489 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 77.12% in 2021, then jumped by 812 bps to 703.02% in 2022, then slumped by 140 bps to 283.48% in 2023, then declined by 11 bps to 314.04% in 2024, then soared by 205 bps to 330.86% in 2025.
- Per Business Quant, the three latest RGNX EBT Margin figures stand at 330.86% (Q4 2025), 220.23% (Q3 2025), and 331.91% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | 330.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 330.86% |
| Sep 30, 2025 | -220.23% |
| Jun 30, 2025 | -331.91% |
| Mar 31, 2025 | 4.06% |
| Dec 31, 2024 | -314.04% |
| Sep 30, 2024 | -248.39% |
| Jun 30, 2024 | -247.60% |
| Mar 31, 2024 | -481.95% |
| Dec 31, 2023 | -283.48% |
| Sep 30, 2023 | -213.97% |
| Jun 30, 2023 | -360.72% |
| Mar 31, 2023 | -348.40% |
| Dec 31, 2022 | 703.02% |
| Sep 30, 2022 | -284.72% |
| Jun 30, 2022 | -208.82% |
| Mar 31, 2022 | -345.50% |
| Dec 31, 2021 | 77.12% |
| Sep 30, 2021 | -189.79% |
| Jun 30, 2021 | -261.58% |
| Mar 31, 2021 | -265.49% |